20/20 BIOLABS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $4.3M | $4.1M |
| FY2024 | — | $1.5M | $1.8M |
| FY2025 | — | $-19.2K | $1.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $4.3M | $4.1M |
| FY2024 | — | $1.5M | $1.8M |
| FY2025 | — | $-19.2K | $1.0M |